1921
Volume 80, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Comparison was made between the parasitemia of Chesson strain in humans and in splenectomized and monkeys. In the monkeys, 56.3% of the animals had maximum counts > 25,000/μL and in humans 59.6% were above this peak parasitemia. In humans, it took an average of 9.3 days to reach the maximum parasite count. In monkeys with no previous infections, it took an average of 18.9 days to reach the maximum parasite count; for those with previous infections, it took an average of 15 days. Human and nonhuman primate data on this parasite suggest that splenectomized monkeys, particularly and to a somewhat lesser extent can mimic the course of Chesson malaria in humans regarding parasitemia and mosquito infection.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2009.80.152
2009-01-01
2017-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/80/1/0800152.html?itemId=/content/journals/10.4269/ajtmh.2009.80.152&mimeType=html&fmt=ahah

References

  1. Ehrman FC, Ellis JM, Young MD, 1945. Plasmodium vivax Chesson strain. Science 101 : 377.
  2. Moore JA, Young MD, Hardman NF, Stubbs TH, 1945. Studies on imported malarias: 2. Ability of California anophelines to transmit malarias of foreign origin and other considerations. J Natl Malar Soc 4 : 307–329.
  3. Young MD, Ellis JM, Stubbs TH, 1946. Studies on imported malarias. 5. Transmission of foreign Plasmodium vivax by Anopheles quadrimaculatus. Am J Trop Med 26 : 477–482.
  4. Young MD, Stubbs TH, Ellis JM, Burgess RW, Eyles DE, 1946. Studies on imported malarias. 5. The infectivity of malarias of foreign origin to anophelines of the southern United States. Am J Hyg 43 : 326–341.
  5. Whorton CM, Kirschbaum WR, Pullman TN, Jones R Jr, Craige B Jr, Alving AS, Eichelberger L, Coultson F, 1947. The Chesson strain of Plasmodium vivax malaria. 1. Factors influencing the incubation period. J Infect Dis 80 : 223–227.
  6. Craige B Jr, Alving AS, Jones R Jr, Whorton CM, Pullman TN, Eichelberger L, 1947. The Chesson strain of Plasmodium vivax malaria. II. Relationship between prepatent period, latent period and relapse rate. J Infect Dis 80 : 228–236.
  7. Whorton CM, Yount E Jr, Jones R Jr, Alving AS, Pullman TN, Craige B Jr, Eichelberger L, 1947. The Chesson strain of Plasmodium vivax malaria. III. Clinical aspects. J Infect Dis 80 : 237–249.
  8. Whorton CM, Pullman TN, Kirschbaum WR, Jones R Jr, Alving AS, Craige B Jr, Eichelberger L, Coulston F, 1947. The Chesson strain of Plasmodium vivax malaria. IV. Immunity. J Infect Dis 81 : 1–6.
  9. Craige B, Jones R Jr, Whorton CM, Pullman TN, Alving AS, Eichelberger L, 1947. Clinical standardization of pamaquine (Plasmoquine) in mosquito-induced vivax malaria, Chesson strain. A preliminary report. Am J Trop Med 27 : 309–315.
  10. Young MD, Ellis JM, Stubbs TH, 1947. Some characteristics of foreign vivax malaria induced in neurosyphilitic patients. Am J Trop Med 27 : 585–596.
  11. Alving AS, 1948. Pentaquine (SN-13,276) and isopentaquine (SN-13,274). Therapeutic agents effective in reducing relapse rate in vivax malaria. Proceedings of the 4th International Congress of Tropical Medicine and Malaria, June 1948; Washington, DC.
  12. Alving AS, Craige B Jr, Jones R Jr, Whorton CM, Pullman TN, Eichelberger L, 1948. Pentaquine (SN-13,276), a therapeutic agent effective in reducing the relapse rate in vivax malaria. J Clin Invest 28 : 25–33.
  13. Alving AS, Pullman TN, Craige B Jr, Jones R Jr, Whorton CM, Eichelberger L, 1948. The clinical trial of eighteen analogues of pamaquine (Plasmochin) in vivax malaria (Chesson strain). J Clin Invest 27 : 34–35.
  14. Jones R Jr, Craige B Jr, Alving AS, Whorton CM, Pullman TN, Eichelberger L, 1948. A study of the prophylactic effectiveness of several 9-aminoquinolines in sporozoite -induced vivax malaria (Chesson strain). J Clin Invest 27 : 6–11.
  15. Jones R Jr, Pullman TN, Whorton CM, Craige B Jr, Alving AS, Eichelberger L, 1948. The therapeutic effectiveness of large doses of Paludrine in acute attacks of sporozoite-induced vivax malaria (Chesson strain). J Clin Invest 27 : 51–55.
  16. Pullman TN, Alving AS, Jones R Jr, Whorton CM, Craige B Jr, Eichelberger L, 1948. A study of the prophylactic, curative and suppressive activity of SN-11437 (Metachloridine) in standand infection of vivax malaria. Am J Trop Med 28 : 413–423.
  17. Pullman TN, Craige B Jr, Alving AS, Whorton CM, Jones R Jr, Eichelberger L, 1948. Comparison of chloroquine, quinacrine (atabrine), and quinine in the treatment of acute attacks of sporozoite-induced vivax malaria (Chesson strain). J Clin Invest 27 : 46–50.
  18. Pullman TN, Eichelberger L, Alving AS, Jones R Jr, Craige B Jr, Whorton CM, 1948. The use of SN-10,275 in the prophylaxis and treatment of sporozoite-induced vivax malaria (Chesson strain). J Clin Invest 27 : 12–16.
  19. Young MD, 1948. Adaptibility of exotic malaria parasites to indigenous anophelines. Proceedings of the 4th International Congress of Tropical Medicine and Malaria, June 1948; Washington, DC.
  20. Coatney GR, Cooper WC, Ruhe DS, Young MD, 1949. Studies in human malaria. XVII. Trials of quinacrine, colchicine (SN 12,080) and quinine against Chesson strain vivax malaria. Am J Hyg 50 : 194–200.
  21. Cooper WC, Coatney GR, Imboden CA Jr, Jeffery GM, 1949. Aureomycin in experimental Chesson strain vivax malaria. Proc Soc Exp Biol Med 72 : 587–588.
  22. Coatney GR, Cooper WC, Eyles DE, Culwell WB, White WC, Lints HA, 1950. Studies in human malaria. XXVII. Observations on the use of pentaquine in the prevention and treatment of Chesson strain vivax malaria. J Natl Malar Soc 9 : 222–233.
  23. Coatney GR, Cooper WC, White WC, Lints HA, Culwell WB, Eyles DE, 1950. Studies in human malaria. XXIV. Protective and therapeutic trials of SN 10,751 (Camoquine) against the Chesson strain of Plasmodium vivax. J Natl Malar Soc 9 : 67–73.
  24. Coatney GR, Cooper WC, Young MD, 1950. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J Natl Malar Soc 9 : 381–396.
  25. Cooper WC, Coatney GR, Culwell WB, Eyles DE, Young MD, 1950. Studies in human malaria. XXVI. Simultaneous infection with the Chesson and the St. Elizabeth strains of Plasmodium vivax. J Natl Malar Soc 9 : 182–190.
  26. Cooper WC, Coatney GR, Jeffery GM, Imboden CA Jr, 1950. Studies in human malaria. XXVIII. Observations on the use of chlorguanide against Chesson strain of Plasmodium vivax. J Natl Malar Soc 9 : 366–376.
  27. Edgecomb HJ, Arnold J, Young EH Jr, Alving AS, Eichelberger L, Jeffery GM, Eyles D, Young MD, 1950. Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J Natl Malar Soc 9 : 285–292.
  28. Imboden CA Jr, Cooper WC, Coatney GR, Jeffery GM, 1950. Studies in human malaria. XXIX. Trials of aureomycin, chloramphenicol, penicillin and dihydrostreptomycin against the Chesson strain of Plasmodium vivax. J Natl Malar Soc 9 : 377–380.
  29. Lints HA, Coatney GR, Cooper WC, Culwell WB, White WC, Eyles DE, 1950. Studies in human malaria. XXII. Prolonged suppression of Chesson strain vivax malaria by the weekly administration of chlorquanide or chloroquine. J Natl Malar Soc 9 : 50–58.
  30. Alving AS, Alnold J, Robinson DH, 1952. Status of Primaquine 1. Mass therapy of subclinical vivax malaria with primaquine. JAMA 149 : 1558–1562.
  31. Coatney GR, Myatt AV, Hernandez T, Jeffery GM, Cooper WC, 1952. Symposium on daraprim. Studies on the compound 50–63. Trans R Soc Trop Med Hyg 46 : 496–497.
  32. Jeffery GM, 1952. The infection of mosquitoes by Plasmodium vivax (Chesson strain) during the early primary parasitemias. Am J Trop Med Hyg 1 : 612–617.
  33. Cooper WC, Myatt AV, Hernandez T, Jeffery GM, Coatney GR, 1953. Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria. Am J Trop Med Hyg 2 : 949–957.
  34. Hernandez T, Myatt AV, Coatney GR, Jeffery GM, 1953. Studies in human malaria. XXXIV. Acquired resistance to pyrimethamine (Daraprim) by the Chesson strain of Plasmodium vivax. Am J Trop Med Hyg 2 : 797–804.
  35. Coatney GR, Myatt AV, Hernandez T, Jeffery GM, Cooper WC, 1953. Studies in human malaria. XXXII. The protective and therapeutic effects of pyrimethamine (Daraprim) against Chesson strain vivax malaria. Am J Trop Med Hyg 2 : 777–787.
  36. Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Jeffery GM, 1954. The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria. J Lab Clin Med 44 : 429–438.
  37. Jeffery GM, Burgess RW, Eyles DE, 1954. Susceptibility of Anopheles quadrimaculatus and A. albimanus to domestic and foreign strains of Plasmodium vivax. Am J Trop Med Hyg 3 : 821–824.
  38. Alving AS, Arnold J, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Flanagan CL, 1955. Potentiation of the curative action of primaquine in vivax malaria by primaquine and chloroquine. J Lab Clin Med 46 : 301–306.
  39. Young MD, Eyles DE, Burgess RW, Jeffery GM, 1955. Experimental testing of the immunity of negros to Plasmodium vivax. J Parasitol 41 : 315–318.
  40. Jeffery GM, 1956. Relapses with Chesson strain Plasmodium vivax following treatment with chloroquine. Am J Trop Med Hyg 5 : 1–13.
  41. Jeffery GM, 1958. Infectivity to mosquitoes of Plasmodium vivax following treatment with chloroquine and other antimalarials. Am J Trop Med Hyg 7 : 207–211.
  42. Coatney GR, Michelson O, Burgess RW, Young MD, Pirkle CI, 1958. Chloroquine and pyrimethamine in salt as a suppressive against sporozoite-induced vivax malaria (Chesson strain). Bull World Health Organ 19 : 53–67.
  43. Young MD, Burgess RW, 1959. Pyrimethamine resistance in Plasmodium vivax malaria. Bull World Health Organ 20 : 27–36.
  44. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE, 1960. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration. Bull World Health Organ 22 : 621–631.
  45. Arnold J, Alving AS, Clayman CB, 1961. Induced primaquine resistance in vivax malaria. Trans R Soc Trop Med Hyg 55 : 345–350.
  46. Kuvin SF, Tobie JE, Evans CB, Coatney GR, Contacos PG, 1962. Fluorescent antibody studies on the course of antibody production and serum gamma globulin levels in normal volunteers infected with human and simian malarias. Am J Trop Med Hyg 11 : 429–436.
  47. Tobie JE, Kuvin SF, Contacos PG, Coatney GR, Evans CB, 1962. Fluorescent antibody studies on cross reactions between human and simian malaria in normal volunteers. Am J Trop Med Hyg 11 : 589–596.
  48. Coatney GR, Contacos PG, Lunn JS, Kilpatrick JW, Elder HA, 1963. The effect of a repository preparation of the dihydrotriazine metabolite of chlorguanide, CI-501, against the Chesson strain of Plasmodium vivax in man. Am J Trop Med Hyg 12 : 504–508.
  49. Contacos PG, Elder HA, Coatney GR, 1963. Therapeutic trials of a dihydroxynaphthalene (377C54) against Plasmodium falciparum and Plasmodium vivax infections in human volunteers. Am J Trop Med Hyg 12 : 513–518.
  50. Hill GJ II, Knight V, Coatney GR, Lawless DE, 1963. Vivax malaria complicated by aphasia and hemiparesis. Arch Intern Med 112 : 863–868.
  51. Coatney GR, Contacos PG, Lunn JS, 1964. Further observations on the antimalarial activity of CI-501 (Camolar) against the Chesson strain of vivax malaria. Am J Trop Med Hyg 13 : 383–385.
  52. Chin W, Lunn JS, Buxbaum J, Contacos PG, 1965. The effect of cycloguanil pamoate (CI -501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax. Am J Trop Med Hyg 14 : 922–924.
  53. Lunn JS, Jacobs RL, Contacos PG, Coatney GR, 1965. Antibody production in Plasmodium vivax infections suppressed by weekly doses of chloroquine. Am J Trop Med Hyg 14 : 697–699.
  54. Powell RD, DeGowin RL, Eppes RB, 1965. Studies on the antimalarial effects of cycloguanil pamoate (CI-501) in man. Am J Trop Med Hyg 14 : 913–921.
  55. Rubenstein M, Mulholland JH, Jeffery GM, Wolff SM, 1965. Malaria induced endotoxin tolerance. Proc Soc Exp Biol Med 118 : 283–287.
  56. Chin W, Contacos PG, Coatney GR, 1966. The evaluation of quinine sulfate and diaminodiphenyl sulfone (DDS) as suppressive agents against sporozoite-induced Chesson strain vivax malaria. Am J Trop Med Hyg 15 : 922–924.
  57. Contacos PG, Coatney GR, Lunn JS, Chin W, 1966. The urinary excretion and antimalarial activity of CI-501 (cycloguanil pamoate) against vivax and falciparum malaria. Am J Trop Med Hyg 15 : 281–286.
  58. Jeffery GM, 1966. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull World Health Organ 35 : 873–882.
  59. Lunn JS, Chin W, Contacos PG, Coatney GR, 1966. Changes in antibody titers and serum protein fractions during the course of prolonged infections with vivax or with falciparum malaria. Am J Trop Med Hyg 15 : 3–10.
  60. Tobie JE, Abele DC, Hill GJ II, Contacos PG, Evans CB, 1966. Fluorescent antibody studies on the immune response in sporozoite-induced and blood-induced vivax malaria and the relationship of antibody production to parasitemia. Am J Trop Med Hyg 15 : 676–683.
  61. Tobie JE, Wolff SM, Jeffery GM, 1966. Immune response of man to inoculation with Plasmodium cnomolgi and challenge with P. vivax. Lancet 2 : 300–302.
  62. Chin W, Coatney GR, King HK, 1967. An evaluation of CI-564 against blood-induced chlorguanide-sensitive and chlorguanide-resistant strains of vivax malaria. Am J Trop Med Hyg 16 : 13–14.
  63. Clyde DF, Miller RM, DuPont HL, Hornick RB, 1971. Antimalarial effects of tetracyclines in man. J Trop Med Hyg 74 : 238–242.
  64. Clyde DF, Rebert CC, McCarthy VC, Miller RM, 1971. Prophylaxis of malaria in man using the sulfones DFD and DDS alone and with chloroquine. Mil Med 136 : 836–841.
  65. Coatney GR, Collins WE, Warren McW, Contacos PG, 1971. The Primate Malarias. Washington, DC: US Govt. Printing Office.
  66. Contacos PG, Coatney GR, Collins WE, Briesch PE, Jeter MH, 1973. Five day primaquine therapy: an evaluation of radical curative activity against vivax amalaria infection. Am J Trop Med Hyg 22 : 693–695.
  67. Neva FA, Howard WA, Glew RH, Krotoski WA, Gam AA, Collins WE, Atkinson JP, Frank MM, 1974. Relationship of serum complement levels to events of the malaria paroxysm. J Clin Invest 54 : 451–460.
  68. Ungureanu E, Killick-Kendrick R, Garnham PCC, Branzel P, Ramanescu C, Shute PG, 1976. Prepatent periods of a tropical strain of Plasmodium vivax after inoculation of tenfold dilutions of sporozoites. Trans R Soc Trop Med Hyg 70 : 482–483.
  69. Ward RA, Rutledge LC, Hickman RL, 1969. Cyclical transmission of Chesson vivax malaria to subhuman primates. Nature 224 : 1126–1127.
  70. Schmidt LH, 1978. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus) I. The courses of untreated infections. Am J Trop Med Hyg 27 : 671–702.
  71. Schmidt LH, 1978. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus) II. Responses to chloroquine, quinine, and pyrimethamine. Am J Trop Med Hyg 27 : 703–717.
  72. Schmidt LH, 1978. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus) III. Methods employed in the search for new blood schizonticidal drugs. Am J Trop Med Hyg 27 : 718–737.
  73. Collins WE, Warren McW, Contacos PG, Skinner JC, Richardson BB, Kearse TS, 1980. The Chesson strain of Plasmodium vivax in Aotus monkeys and anopheline mosquitoes. J Parasitol 66 : 488–497.
  74. Collins WE, Skinner JC, Broderson JR, Mehaffey P, Sutton BB, 1985. Infection of Aotus azarae boliviensis monkeys with different strains of Plasmodium vivax. J Parasitol 71 : 239–243.
  75. Collins WE, Skinner JC, Pappaioanou M, Ma NF-S, Broderson JR, Sutton BB, Stanfill PS, 1987. Infection of Aotus vociferans (karyotype V) monkeys with different strains of Plasmodium vivax. J Parasitol 73 : 536–540.
  76. Collins WE, Skinner JC, Pappaioanou M, Broderson JR, Ma NS-F, Filipski V, Stanfill PS, Rogers L, 1988. Infection of Peruvian Aotus nancymai monkeys with different strains of Plasmodium falciparum, P. vivax, and P. malariae. J Parasitol 74 : 392–398.
  77. Collins WE, McClure HM, Swenson RB, Mehaffey P, Skinner JC, 1986. Infection of mosquitoes with Plasmodium vivax from chimpanzees using membrane feeding. Am J Trop Med Hyg 35 : 56–60.
  78. Collins WE, Jeffery GM, 1999. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum. Am J Trop Med Hyg 61 (Suppl): 4–48.
  79. Earle WC, Perez M, 1932. Enumeration of parasites in the blood of malarial patients. J Lab Clin Med 17 : 1124–1130.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2009.80.152
Loading
/content/journals/10.4269/ajtmh.2009.80.152
Loading

Data & Media loading...

  • Received : 17 Sep 2008
  • Accepted : 24 Sep 2008

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error